Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients

Romero Ventosa, Elena Yaiza; González Piñeiro, Ana Lourdes; Piñeiro Corrales, María Guadalupe
Thumbnail
Estatísticas
Estatísticas
Identificadores
Identificadores
URI: http://hdl.handle.net/20.500.11940/5493
PMID: 25918681
ISSN: 2193-180
Rexistro completo
Servizos
Servizos
RISMendeleyLinksolver
Data de publicación
2015
Tipo de contido
Artigo